Bo Zhang | Neuropsychiatric Disorders | Best Researcher Award

Prof. Dr. Bo Zhang | Neuropsychiatric Disorders | Best Researcher Award

Shenzhen Bay laboratory | China

Author Profile

Scopus

Orcid ID

Google Scholar

🔗 Bo Zhang, PhD: Principal Investigator, Neuroscience Innovator

🎓 EARLY ACADEMIC PURSUITS

Bo Zhang was born in January 1983. He earned his Ph.D. from the Institute of Molecular Medicine at Peking University (2005-2011) under the mentorship of Prof. Zhuan Zhou, where his groundbreaking doctoral research laid the foundation for his career in neuroscience. Bo’s academic pursuit continued with a postdoctoral position at the Howard Hughes Medical Institute and Stanford University School of Medicine (2011-2017) under Nobel laureate Prof. Thomas Südhof. During this time, he contributed significantly to understanding the molecular basis of synaptic function.

🧠 PROFESSIONAL ENDEAVORS

Bo Zhang's illustrious career spans appointments in China and the United States, including:

  • Principal Investigator at Shenzhen Bay Laboratory (2020-present)
  • Joint Principal Investigator at Peking University Shenzhen Graduate School (2019-present)
  • Research Scientist at Stanford University School of Medicine (2017-2018)
    Bo Zhang leads a cutting-edge research lab focusing on synaptic function and its connection to neurodevelopmental disorders, especially autism. His roles extend to administrative leadership as Associate Director of the Department of Scientific Research at SZBL and Chair of the admission committee for the PKU-SZBL joint Ph.D. program.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON NEUROPSYCHIATRIC DISORDERS

Dr. Bo Zhang’s research delves into:

  • Mechanisms of Synapse Formation and Function: Exploring how synapses operate at the molecular level to facilitate brain communication.
  • Neurodevelopmental Disorders: Investigating autism-associated genes, including neurexins, neuroligins, and their roles in neural circuitry.
  • Drug Development and Diagnostics: Developing mechanisms for early diagnosis and therapeutic interventions for Alzheimer's and autism-related disorders.
    Key projects include the study of autism-associated genetic deletions and the biological underpinnings of neurodevelopmental deficits.

🌟 IMPACT AND INFLUENCE

Bo Zhang has profoundly influenced neuroscience through innovative research and effective mentoring. His substantial funding record, totaling over 12 million RMB, reflects the importance and promise of his work. Noteworthy grants include projects under the National Natural Science Foundation of China and the Shenzhen-Hong Kong Institute of Brain Science.

His guidance has produced award-winning graduate students, such as Ying Hang, a co-chair at the 49th SFN Meeting and a recipient of the prestigious SZBL Director Scholarship. Bo’s leadership ensures a pipeline of talented researchers contributing to neuroscience globally.

📚 ACADEMIC CITES AND PUBLICATIONS

Bo Zhang has contributed extensively to the neuroscience field, co-authoring publications that are heavily cited, affirming his position as an authority in synaptic biology and neurodevelopmental research.

🏅 LEGACY AND FUTURE CONTRIBUTIONS

Dr. Zhang has not only advanced our understanding of autism and synaptic mechanisms but also set the stage for the next wave of discoveries in neural disorders and therapeutics. His work promises impactful breakthroughs in diagnosing and treating neurodevelopmental and degenerative diseases.

🌏 SELECTIVE INVITED TALKS AND COMMUNITY SERVICE

Bo Zhang’s expertise is recognized globally. Highlights include chairing the Social Brain Symposium (2025) and delivering keynote talks at major neuroscience conferences like the CNS International Meeting (2023) and the International Symposium on Synaptic Transmission and Neural Plasticity (2023).

His contributions to the broader scientific community include serving as Associate Editor of Frontiers in Synaptic Neuroscience and a committee member for The Biophysical Society of China.

🏆 HONORS AND RECOGNITIONS

Dr. Zhang’s numerous accolades underline his excellence:

  • National Science Fund for Excellent Young Scholars (2020)
  • Overseas Top Young Talent - Guangdong Pearl River Talent Program (2019)
  • Shenzhen Special Allowance Expert (2022)
    His awards celebrate his innovative research, mentorship, and community contributions.

🌟 CONCLUSION

Bo Zhang, PhD, stands as a beacon in neuroscience, merging innovation and mentorship with his deep commitment to uncovering the mysteries of the brain. His enduring contributions are laying the groundwork for a new era of understanding neurodevelopmental disorders, transforming diagnostics, and improving treatments.

📑 NOTABLE PUBLICATIONS 

"Astrocytic Neuroligin-3 influences gene expression and social behavior, but is dispensable for synapse number

  • Authors: Qin, L. , Liu, Z. , Guo, S. , Sun, Y. , Zhang, B.
  • Journal: Molecular Psychiatry
  • Year: 2025

"Neurexin-3 subsynaptic densities are spatially distinct from Neurexin-1 and essential for excitatory synapse nanoscale organization in the hippocampus

  • Authors: Lloyd, B.A. , Han, Y. , Roth, R. , Zhang, B. , Aoto, J.
  • Journal: Nature Communications
  • Year: 2023

"Editorial: Signaling mechanisms of synapse assembly

  • Authors: Liu, Z. , Sando, R. , Zhang, B. , Yang, X.
  • Journal: Frontiers in Synaptic Neuroscience
  • Year: 2023

"Cocaine increases quantal norepinephrine secretion through NET-dependent PKC activation in locus coeruleus neurons

  • Authors: Zhu, F. , Liu, L. , Li, J. , Xu, Z.-Q.D. , Zhou, Z.
  • Journal: Cell Reports
  • Year: 2022

"Neuroligin-3 confines AMPA receptors into nanoclusters, thereby controlling synaptic strength at the calyx of Held synapses

  • Authors: Han, Y., Cao, R., Qin, L., Südhof, T.C., Zhang, B.
  • Journal: Science Advances
  • Year: 2022

Ebru Dundar-Yenilmez | Neurogenetics and Neuropsychiatric Disorders | Best Researcher Award

Prof Dr. Ebru Dundar-Yenilmez | Neurogenetics and Neuropsychiatric Disorders | Best Researcher Award

Cukurova University | Turkey

AUTHOR PROFILE

Scopus

Orcid ID

Google Scholar

EARLY ACADEMIC PURSUITS

Ebru Dündar Yenilmez began her academic journey with a Bachelor's degree in Biology from Çukurova University's Faculty of Science and Literature. This foundational education laid the groundwork for her future pursuits in biochemistry and genetics. She continued her studies at the same university, undertaking a Master's degree followed by a PhD in Biochemistry from the Institute of Health Science. These early academic pursuits provided her with a comprehensive understanding of biological systems, paving the way for her specialization in molecular biochemistry, epigenetics, and pharmacogenetics.

PROFESSIONAL ENDEAVORS

Following the completion of her PhD, Ebru Dündar Yenilmez embarked on a career as a research assistant at Çukurova University's Faculty of Medicine, Department of Medical Biochemistry. Over the years, she demonstrated excellence in research and teaching, leading to her appointment as a lecturer upon obtaining her doctorate. Her dedication to academia and her field is evident in her commitment to teaching medical biochemistry at both the Medicine and Dentistry faculties.

CONTRIBUTIONS AND RESEARCH FOCUS ON NEUROGENETICS AND NEUROPSYCHIATRIC DISORDERS

Ebru Dündar Yenilmez has made significant contributions to the fields of molecular biochemistry, epigenetics, pharmacogenetics, and molecular diagnostics techniques. Her research endeavors have focused on understanding the molecular basis of hereditary diseases, with a particular emphasis on the role of DNA and RNA in disease pathogenesis. Through her work, she has advanced our understanding of complex biological processes and paved the way for the development of novel diagnostic and therapeutic approaches.

IMPACT AND INFLUENCE

As a member of esteemed organizations such as the European Society of Human Genetics, Turkish Society of Biochemistry, and European Society Pharmacogenomics and Personalized Therapy, Ebru Dündar Yenilmez has actively contributed to the global scientific community. Her research findings have been disseminated through publications in prestigious journals and presentations at international conferences, amplifying her impact and influence within her field.

ACADEMIC CITATIONS

Ebru Dündar Yenilmez's contributions to academia are reflected in her citation record, with her research being cited by peers and scholars across the globe. Her work serves as a cornerstone for further research and exploration in molecular biochemistry and related disciplines, further solidifying her position as a respected authority in her field.

LEGACY AND FUTURE CONTRIBUTIONS

Ebru Dündar Yenilmez's legacy extends beyond her individual accomplishments, encompassing the students she has mentored and the knowledge she has imparted. As she continues her academic journey, she remains dedicated to pushing the boundaries of scientific understanding and fostering the next generation of researchers. Her future contributions hold the promise of further unraveling the complexities of molecular biology and advancing personalized medicine for the benefit of society.

NOTABLE PUBLICATIONS

Cord Blood Hematological Parameters of Fetuses Detected Different Thalassemia Genotypes in the Second Trimester of Pregnancy 2023 (2)

The effect of Vitamin D on testosterone and uncarboxylated osteocalcin levels in aged male rats 2022

Investigation of beta globin gene mutations in Syrian refugee patients with thalassemia major 2019(2)

Beneficial effects of rolipram, a phosphodiesterase 4 specific inhibitor, on testicular torsion-detorsion injury in rats 2018(16)

A new biosensor for noninvasive determination of fetal RHD status in maternal blood of RhD negative pregnant women 2018(11)